Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Annals of the American Thoracic Society
|
February 11, 2025
Factors Associated with Referral to Expert Providers among Patients with Pulmonary Hypertension
Kari R Gillmeyer, Seppo T Rinne, Justin M Rucci, et al.
Annals of the American Thoracic Society
|
December 9, 2022
Scoping Review of Pulmonary Telemedicine Consults: Current Knowledge and Research Gaps
Brandon Li, Kari R Gillmeyer, Brianne Molloy-Paolillo, et al.
Chest
|
August 11, 2022
Inhaled Nitric Oxide vs Epoprostenol During Acute Respiratory Failure: An Observational Target Trial Emulation
Nicholas A Bosch, Anica C Law, Emily A Vail, et al.
Pulmonary Circulation
|
December 26, 2022
Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension
Kari R Gillmeyer, Seppo T Rinne, Shirley X Qian, et al.
Pulmonary Circulation
|
October 14, 2022
Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity
Ruchika A Sangani, Justin K Lui, Kari R Gillmeyer, et al.
Annals of the American Thoracic Society
|
April 27, 2019
Multisystem Healthcare Use among U.S. Veterans with Pulmonary Hypertension
Kari R Gillmeyer, Kyung M Lee, Qing Shao, et al.
Chest
|
November 10, 2024
Sarcoidosis Treatment Patterns in the United States: 2016-2022
Ruchika Sangani, Nicholas A Bosch, Praveen Govender, et al.
Annals of the American Thoracic Society
|
March 3, 2023
Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia
Brandon Pang, Lauren Kearney, Jennifer Maccarone, et al.
Annals of the American Thoracic Society
|
March 21, 2022
Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy
Shelsey W Johnson, Kari R Gillmeyer, Rendelle E Bolton, et al.
ERJ Open Research
|
May 21, 2024
Cluster analysis identifies novel real-world lung disease-pulmonary hypertension subphenotypes: implications for treatment response
Shelsey W Johnson, Rui-Sheng Wang, Michael R Winter, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Annals of the American Thoracic Society
|
February 11, 2025
Factors Associated with Referral to Expert Providers among Patients with Pulmonary Hypertension
Kari R Gillmeyer, Seppo T Rinne, Justin M Rucci, et al.
Annals of the American Thoracic Society
|
December 9, 2022
Scoping Review of Pulmonary Telemedicine Consults: Current Knowledge and Research Gaps
Brandon Li, Kari R Gillmeyer, Brianne Molloy-Paolillo, et al.
Chest
|
August 11, 2022
Inhaled Nitric Oxide vs Epoprostenol During Acute Respiratory Failure: An Observational Target Trial Emulation
Nicholas A Bosch, Anica C Law, Emily A Vail, et al.
Pulmonary Circulation
|
December 26, 2022
Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension
Kari R Gillmeyer, Seppo T Rinne, Shirley X Qian, et al.
Pulmonary Circulation
|
October 14, 2022
Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity
Ruchika A Sangani, Justin K Lui, Kari R Gillmeyer, et al.
Annals of the American Thoracic Society
|
April 27, 2019
Multisystem Healthcare Use among U.S. Veterans with Pulmonary Hypertension
Kari R Gillmeyer, Kyung M Lee, Qing Shao, et al.
Chest
|
November 10, 2024
Sarcoidosis Treatment Patterns in the United States: 2016-2022
Ruchika Sangani, Nicholas A Bosch, Praveen Govender, et al.
Annals of the American Thoracic Society
|
March 3, 2023
Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia
Brandon Pang, Lauren Kearney, Jennifer Maccarone, et al.
Annals of the American Thoracic Society
|
March 21, 2022
Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy
Shelsey W Johnson, Kari R Gillmeyer, Rendelle E Bolton, et al.
ERJ Open Research
|
May 21, 2024
Cluster analysis identifies novel real-world lung disease-pulmonary hypertension subphenotypes: implications for treatment response
Shelsey W Johnson, Rui-Sheng Wang, Michael R Winter, et al.
Page
of 3